Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Prenatal array comparative genome hybridisation (aCGH) testing has by and large replaced routine karyotyping in many healthcare settings. While this will lead to more diagnoses, uncertain, unexpected or unhelpful findings are also likely to increase. This is the case for aCGH in any setting, but we discuss the particular challenges the prenatal setting generates and suggest areas that need further debate and discussion as well as some pragmatic ways forward.

Original publication

DOI

10.1136/archdischild-2013-304835

Type

Journal article

Journal

Archives of disease in childhood. Fetal and neonatal edition

Publication Date

07/2014

Volume

99

Pages

F338 - F341

Keywords

Humans, Fetal Diseases, Chromosome Disorders, Prenatal Diagnosis, Incidental Findings, Parents, Choice Behavior, Pregnancy, Female, Comparative Genomic Hybridization